Karen Gascoigne - Scientist, Discovery Oncology

Karen Gascoigne

Scientist, Discovery Oncology

"It is inspiring to go to work each day knowing there is an opportunity to change patients lives with our science."
5
Years at Genentech
6
Publications
4
Awards & Honors

I completed my postdoctoral research at the Whitehead Institute - MIT investigating the molecular determinates of aneuploidy in cancer. In 2013 I joined Genentech as a scientist in the Discovery Oncology department. Our goal is to use a deep molecular understanding of cancer to identify targetable vulnerabilities & contribute to the drug discovery effort.

Postdoctoral Mentor

Genentech’s postdoctoral research program offers a wonderful opportunity to carry out cutting edge cross-disciplinary research in a highly collaborative environment. By leveraging the outstanding research & technology infrastructure at Genentech, postdocs can take on big scientific questions and have a significant impact on their chosen field.

Featured Publication

Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer.

Cancer Res. 2017 Oct 15;77(20):5564-5575.

Jin L, Garcia J, Chan E, de la Cruz C, Segal E, Merchant M, Kharbanda S, Raisner R, Haverty PM, Modrusan Z, Ly J, Choo E, Kaufman S, Beresini MH, Romero FA, Magnuson S, Gascoigne KE.